Feng Y, Liu G, Li H, Cheng L
Sci China Life Sci. 2025; .
PMID: 40035969
DOI: 10.1007/s11427-024-2751-6.
Gu X, Gu S, Chen Z, Tong J, Li X, Dong H
World J Hepatol. 2025; 17(2):99046.
PMID: 40027555
PMC: 11866147.
DOI: 10.4254/wjh.v17.i2.99046.
Alves E, Currenti J, Crawford K, Chopra A, Ram R, Barnett L
Sci Adv. 2025; 11(7):eadr4238.
PMID: 39951541
PMC: 11827868.
DOI: 10.1126/sciadv.adr4238.
Xiang Y, Sun G, Tian L, Xiang P, Xie C
Ann Hematol. 2025; .
PMID: 39918600
DOI: 10.1007/s00277-025-06241-0.
Li J, Zhang Y, Hu L, Ye H, Yan X, Li X
J Clin Transl Hepatol. 2025; 13(1):69-83.
PMID: 39801788
PMC: 11712086.
DOI: 10.14218/JCTH.2024.00238.
Vaccination as a Promising Approach in Cardiovascular Risk Mitigation: Are We Ready to Embrace a Vaccine Strategy?.
Tsioulos G, Vallianou N, Skourtis A, Dalamaga M, Kotsi E, Kargioti S
Biomolecules. 2025; 14(12.
PMID: 39766344
PMC: 11727084.
DOI: 10.3390/biom14121637.
High-throughput specificity profiling of antibody libraries using ribosome display and microfluidics.
Wagner E, Carter K, Lim Y, Chau G, Enstrom A, Wayham N
Cell Rep Methods. 2024; 4(12):100934.
PMID: 39689695
PMC: 11704616.
DOI: 10.1016/j.crmeth.2024.100934.
Integrative mapping of human CD8 T cells in inflammation and cancer.
Xue Z, Wu L, Tian R, Gao B, Zhao Y, He B
Nat Methods. 2024; 22(2):435-445.
PMID: 39614111
DOI: 10.1038/s41592-024-02530-0.
Rapid parallel reconstruction and specificity screening of hundreds of T cell receptors.
Afeyan A, Wu C, Oliveira G
Nat Protoc. 2024; 20(3):539-586.
PMID: 39516267
PMC: 11896752.
DOI: 10.1038/s41596-024-01061-4.
TIRTL-seq: Deep, quantitative, and affordable paired TCR repertoire sequencing.
Pogorelyy M, Kirk A, Adhikari S, Minervina A, Sundararaman B, Vegesana K
bioRxiv. 2024; .
PMID: 39345544
PMC: 11430070.
DOI: 10.1101/2024.09.16.613345.
Human TCR repertoire in cancer.
Chen L, Hu Y, Zheng B, Luo L, Su Z
Cancer Med. 2024; 13(17):e70164.
PMID: 39240157
PMC: 11378360.
DOI: 10.1002/cam4.70164.
The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer.
Shapiro J, Corrado M, Perry J, Watts T, Bolotin S
Hum Vaccin Immunother. 2024; 20(1):2395679.
PMID: 39205626
PMC: 11364080.
DOI: 10.1080/21645515.2024.2395679.
Dissecting the Distinct Tumor Microenvironments of HRD and HRP Ovarian Cancer: Implications for Targeted Therapies to Overcome PARPi Resistance in HRD Tumors and Refractoriness in HRP Tumors.
Qiu J, Ren T, Liu Q, Jiang Q, Wu T, Cheng L
Adv Sci (Weinh). 2024; 11(38):e2309755.
PMID: 39136172
PMC: 11481286.
DOI: 10.1002/advs.202309755.
Implementing distinct spatial proteogenomic technologies: opportunities, challenges, and key considerations.
Verstappe B, Scott C
Clin Exp Immunol. 2024; 218(2):151-162.
PMID: 39133142
PMC: 11482502.
DOI: 10.1093/cei/uxae077.
T cell receptor clonotype in tumor microenvironment contributes to intratumoral signaling network in patients with colorectal cancer.
Song I, Lee S, Jeong B, Park J, Kim H, Lee G
Immunol Res. 2024; 72(5):921-937.
PMID: 39112913
DOI: 10.1007/s12026-024-09478-5.
Specific CD4 T cell phenotypes associate with bacterial control in people who 'resist' infection with Mycobacterium tuberculosis.
Sun M, Phan J, Kieswetter N, Huang H, Yu K, Smith M
Nat Immunol. 2024; 25(8):1411-1421.
PMID: 38997431
PMC: 11291275.
DOI: 10.1038/s41590-024-01897-8.
Preservation of naive-phenotype CD4+ T cells after vaccination contributes to durable immunity.
Pan Y, Bartolo L, Xu R, Patel B, Zarnitsyna V, Su L
JCI Insight. 2024; 9(14).
PMID: 38861490
PMC: 11383171.
DOI: 10.1172/jci.insight.180667.
A Computational Strategy for the Rapid Identification and Ranking of Patient-Specific T Cell Receptors Bound to Neoantigens.
Rollins Z, Curtis M, George S, Faller R
Macromol Rapid Commun. 2024; 45(24):e2400225.
PMID: 38839076
PMC: 11661661.
DOI: 10.1002/marc.202400225.
Deep learning predictions of TCR-epitope interactions reveal epitope-specific chains in dual alpha T cells.
Croce G, Bobisse S, Moreno D, Schmidt J, Guillame P, Harari A
Nat Commun. 2024; 15(1):3211.
PMID: 38615042
PMC: 11016097.
DOI: 10.1038/s41467-024-47461-8.
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy.
Shao W, Yao Y, Yang L, Li X, Ge T, Zheng Y
Exp Hematol Oncol. 2024; 13(1):37.
PMID: 38570883
PMC: 10988985.
DOI: 10.1186/s40164-024-00504-8.